Jean-Michel Pawlotsky chercheur français
Pawlotsky, Jean-Michel, 1961-....
Pawlotsky, Jean-Michel
VIAF ID: 61787609 (Personal)
Permalink: http://viaf.org/viaf/61787609
Preferred Forms
- 100 0 _ ‡a Jean-Michel Pawlotsky ‡c chercheur français
- 200 _ | ‡a Pawlotsky ‡b Jean-Michel
- 100 1 _ ‡a Pawlotsky, Jean-Michel
- 100 1 _ ‡a Pawlotsky, Jean-Michel
-
-
- 100 1 _ ‡a Pawlotsky, Jean-Michel, ‡d 1961-....
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Advanced therapy for hepatitis C | |
Characterization of a new broad spectrum molecules , inhibitors of cyclophilins, on Zika virus and coronavirus replication. | |
Characterization of viral determinants of hepatitis C virus-induced steatosis. | |
Chronic hepatitis B infection, [2007]: | |
Corrélats clinico-virologiques chez les malades ayant une hépatite chronique B AgHBe négative liée au virus de l'hépatite B de génotype D | |
Développement de nouvelles approches thérapeutiques en virologie et hépatologie : Small-Molecule Cyclophilin Inhibitors (SMCypI) | |
Développement d'une nouvelle famille d'inhibiteurs de cyclophilines à large spectre antiviral et étude de leurs mécanismes d'action dans les infections par le Virus de l'Hépatite C et les Coronavirus. | |
Direct impact of the proteins expression of HCV on PI3K-Akt signaling pathway and involvement in the development of hepatocellular carcinoma. | |
Dynamique adaptative des virus hautement variables à un nouvel environnement réplicatif | |
Dynamiques complexes de résistance du virus de l'hépatite B à l'adéfovir dipivoxil | |
EVOLUTION DE LA SEQUENCE DE LA PROTEINE NON STRUCTURALE 5A (NS5A) DU VIRUS DE L'HEPATITE C (VHC) CHEZ UN PATIENT ATTEINT D'HEPATITE CHRONIQUE VIRALE C TRAITE PAR INTERFERON ALPHA (DES BIOL. MED.) | |
Fitness study of hepatitis B virus variants. | |
Hépatite C | |
Hepatitis C virus genetic variability and therapeutic failure. | |
Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection | |
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial). | |
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection | |
In vivo interplay between intrahepatic host innate immune response and HBV reblication. | |
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns | |
Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor Alisporivir (Debio 025) | |
Interactions in vivo entre l'immunité innée intrahépatique et la réplication du virus de l'hépatite B | |
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 Haplotype | |
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. | |
Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing | |
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay | |
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop | |
Lichen planus and hepatitis C virus--related chronic active hepatitis | |
Liver stiffness diminishes with antiviral response in chronic hepatitis C. | |
Long-term hepatitis B surface antigen | |
Low HCV replication levels in end-stage hepatitis C virus-related liver disease | |
[Management of patients with hepatitis C virus infection. Virological tests]. | |
Measuring hepatitis C viremia in clinical samples: can we trust the assays? | |
[Methods of study of the hepatitis C virus genome. Diagnostic tools in human pathology] | |
Microdiversity of <i>Enterococcus faecalis</i> isolates in cases of infective endocarditis: selection of non-synonymous mutations and large deletions is associated with phenotypic modifications | |
Molecular diagnosis of viral hepatitis | |
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users | |
More sensitive hepatitis C virus RNA detection: what for? | |
Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis | |
Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system. | |
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma | |
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin | |
New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development | |
New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase | |
[New therapeutic strategies in chronic hepatitis C]. | |
Non-coding RNA regulation during infection by RNA viruses : Involvment of KSRP for the replication of the Hepatitis C virus and for the Coronoavirus HCoV-229E strain. | |
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C. | |
NS5A sequences of hepatitis C virus genotype 1 and interferon resistance: where are we? | |
Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication | |
Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer | |
Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method | |
Parvovirus B19 and Schönlein-Henoch Purpura in Adults | |
Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment | |
PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma. | |
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort | |
Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots | |
Performance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA Quantification | |
Physiopathologie du traitement de l'hépatite chronique C par les interférons, la ribavirine et les inhibiteurs spécifiques | |
Rôle de la distribution en quasi espèces des virus d'hépatites dans la résistance aux traitements antiviraux et l'évolution de la maladie hépatique | |
Rôle de Programmed cell Death-Ligand 1 dans la progression du carcinome hépatocellulaire | |
Role of quasi species distribution of hepatitis viruses in resistance to antiviral drugs and liver disease progression. | |
SEROPREVALENCE DE L'HEPATITE C A LA REUNION : SIGNIFICATION DES GENOTYPES VIRAUX (DES BIOL. MED.) |